Your browser doesn't support javascript.
loading
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.
Kang, Eun Young; Millstein, Joshua; Popovic, Gordana; Meagher, Nicola S; Bolithon, Adelyn; Talhouk, Aline; Chiu, Derek S; Anglesio, Michael S; Leung, Betty; Tang, Katrina; Lambie, Neil; Pavanello, Marina; Da-Anoy, Annalyn; Lambrechts, Diether; Loverix, Liselore; Olbrecht, Siel; Bisinotto, Christiani; Garcia-Donas, Jesus; Ruiz-Llorente, Sergio; Yagüe-Fernandez, Monica; Edwards, Robert P; Elishaev, Esther; Olawaiye, Alexander; Taylor, Sarah; Ataseven, Beyhan; du Bois, Andreas; Harter, Philipp; Lester, Jenny; Høgdall, Claus K; Armasu, Sebastian M; Huang, Yajue; Vierkant, Robert A; Wang, Chen; Winham, Stacey J; Heublein, Sabine; Kommoss, Felix K F; Cramer, Daniel W; Sasamoto, Naoko; van-Wagensveld, Lilian; Lycke, Maria; Mateoiu, Constantina; Joseph, Janine; Pike, Malcolm C; Odunsi, Kunle; Tseng, Chiu-Chen; Pearce, Celeste L; Bilic, Sanela; Conrads, Thomas P; Hartmann, Arndt; Hein, Alexander.
Affiliation
  • Kang EY; Department of Pathology and Laboratory Medicine, Foothills Medical Center, University of Calgary, Calgary, AB, Canada.
  • Millstein J; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Popovic G; Mark Wainwright Analytical Centre, Stats Central, University of New South Wales Sydney, Sydney, Australia.
  • Meagher NS; School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, NSW, Australia.
  • Bolithon A; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, NSW, Australia.
  • Talhouk A; School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, NSW, Australia.
  • Chiu DS; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, NSW, Australia.
  • Anglesio MS; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, BC, Canada.
  • Leung B; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Tang K; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
  • Lambie N; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, BC, Canada.
  • Pavanello M; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Da-Anoy A; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
  • Lambrechts D; Histopathology/ISH Core Facility, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Loverix L; Prince of Wales Clinical School, University of NSW Sydney, Sydney, NSW, Australia.
  • Olbrecht S; Department of Anatomical Pathology, Prince of Wales Hospital, Sydney, Australia.
  • Bisinotto C; NSW Health Pathology, Prince of Wales Hospital, Sydney, Australia.
  • Garcia-Donas J; Centre for Cancer Research, The Westmead Institute for Medical Research, Westmead, Australia.
  • Ruiz-Llorente S; Department of Pathology and Laboratory Medicine, Foothills Medical Center, University of Calgary, Calgary, AB, Canada.
  • Yagüe-Fernandez M; VIB Center for Cancer Biology, Leuven, Belgium.
  • Edwards RP; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Elishaev E; Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.
  • Olawaiye A; Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.
  • Taylor S; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Ataseven B; HM Sanchinarro Centro Integral Oncológico Clara Campal, University Hospital, Madrid, Spain.
  • du Bois A; HM Sanchinarro Centro Integral Oncológico Clara Campal, University Hospital, Madrid, Spain.
  • Harter P; HM Sanchinarro Centro Integral Oncológico Clara Campal, University Hospital, Madrid, Spain.
  • Lester J; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Høgdall CK; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Armasu SM; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Huang Y; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Vierkant RA; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte (KEM), Essen, Germany.
  • Wang C; Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.
  • Winham SJ; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte (KEM), Essen, Germany.
  • Heublein S; Department of Gynecology and Gynecological Oncology, Dr. Horst-Schmidt Klinik Wiesbaden, Wiesbaden, Germany.
  • Kommoss FKF; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte (KEM), Essen, Germany.
  • Cramer DW; Department of Gynecology and Gynecological Oncology, Dr. Horst-Schmidt Klinik Wiesbaden, Wiesbaden, Germany.
  • Sasamoto N; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
  • van-Wagensveld L; Department of Gynaecology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
  • Lycke M; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
  • Mateoiu C; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Joseph J; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
  • Pike MC; Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, USA.
  • Odunsi K; Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, USA.
  • Tseng CC; Department of Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany.
  • Pearce CL; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Bilic S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Conrads TP; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Hartmann A; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Hein A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Virchows Arch ; 480(4): 855-871, 2022 Apr.
Article de En | MEDLINE | ID: mdl-34782936
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Cystadénocarcinome séreux / Composant-3 du complexe de maintenance des minichromosomes Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Female / Humans Langue: En Journal: Virchows Arch Sujet du journal: BIOLOGIA MOLECULAR / PATOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Canada Pays de publication: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Cystadénocarcinome séreux / Composant-3 du complexe de maintenance des minichromosomes Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Female / Humans Langue: En Journal: Virchows Arch Sujet du journal: BIOLOGIA MOLECULAR / PATOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Canada Pays de publication: Allemagne